Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer

Gynecologic Oncology

Volumn 70, Issue 2, 1998, Pages 195-201

  Santin, Alessandro D ^a,c   Hermonat, Paul L ^a   Ravaggi, Antonella ^a,c   Chiriva Internati, Maurizio ^a,c   Hiserodt, John C ^b   Pecorelli, Sergio ^c   Parham, Groesbeck P ^a  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cervical cancer; ICAM 1; Irradiation; MHC; Retinoic acid

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RETINOIC ACID;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 0032144045     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5060     Document Type: Article

References (40)

1. DiSaia P J, Creasman W T. Cervical Cancer. Clinical Gynecologic Oncology. 1993;Mosby, St. Louis. p. 1-36.
2. Brinton L A. Epidemiology of Cervical Cancer: Overview. Munoz N, Bosh F, Shah K V, Meheus A. The Epidemiology of Human Papillomavirus and Cervical Cancer. 1992;3-23 IARC, Lyon.
3. Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer. 58:1988;611-616.
4. Rellihan M A, Dooley D P, Burke T W, Berkland M E, Longfield R N. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol. 36:1990;435-438.
5. Hall E J. Time, dose, and fractionation in radiotherapy. Radiobiology for the Radiologist. 1988;Lippincott, Philadelphia. p. 239-259.
6. Hareyama M, Imai K, Kubo K, Takahashi H, Koshiba H, Hinoda Y, Shidou M, Oouchi A, Yachi A, Kazuo M. Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells. Cancer. 67:1991;2269-2274.
7. b. Cancer Res. 53:1993;1952-1955.
8. Sporn M B, Roberts A B. Role of retinoids in differentiation and carcinogenesis. Cancer Res. 43:1983;3034-3040.
9. Bollag W, Holdener E E. Retinoids in cancer prevention and therapy. Annu Oncol. 3:1992;513-526.
10. Bertram J S, Kolonel L N, Meyskens F L. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 47:1987;3012-3031.
11. Choo C K, Rorke E A, Eckert L R. Retinoids regulation of cell differentiation in a series of human papillomavirus type 16-immortalized human cervical epithelial cell lines. Carcinogenesis. 16:1995;375-381.
12. Graham V, Surwit E S, Weiner S, Meyskens F L. Phase II trial of β-all-trans-retinoids acid for cervical intraepithelia neoplesia delivered via a collagen sponge and cervical cap. West J Med. 145:1986;192-195.
13. Meyskens F L, Graham V, Chvapil M, Dorr R T, Alberts D S, Surwit E S. A phase I trial of β-all-trans-retinoids acid delivered via a collagen sponge and cervical cap for mild and moderate intraepithelia cervical neoplesia. J Natl Cancer Inst. 71:1983;921-925.
14. Lippman S M, Kavanagh J J, Paredes-Espinoza M, Degaldillo-Madrueno F, Paredes-Casillas P, Ki Hong W, Holdener E, Krakoff I H. 13-cis-retinoids acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst. 84:1992;241-245.
15. Lippman S M, Kavanagh J J, Paredes-Espinoza M, Degaldillo-Madrueno F, Paredes-Casillas P, Ki Hong W, Giorgio Massimini, Holdener E, Krakoff I H. 13-cis-retinoids acid plus interferon α-2a in locally advanced squamous cell carcinoma of the cervix. J Natl Cancer Inst. 85:1993;499-500.
16. Rutz H, Little J B. Modification of radiosensitivity and recovery from X-ray damage in vitro by retinoic acid. Int J Radiat Oncol Biol Phys. 16:1989;1285-1288.
17. Hoffmann W, Schiller U, Rodemann H P, Bamberg M. Vitamin A in cancer treatment: impact of clinical and preclinical data on radio-oncology. Strahlenther Onkol. 171:1995;106-112.
18. Yee C, Krishhnan-Hewlett I, Backer C C, Schlegel R, Howley P M. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol. 119:1985;361-366.
19. Benner S E, Fritsche H A, Lee J S, Lippman S M, Hong W K. Serum retinols levels following 13-cis-retinoic acid administration in a chemioprevention trial. Proc Am Assoc Cancer Res Abs. 3504:1995;36,588.
20. Chen L, Thomas E K, Hu S-L, Hellstrom I, Hellstrom K E. Human papilloma virus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci USA. 88:1991;110-114.
21. Meneguzzi G, Cerni C, Kieny M P, Lathe R. Immunization against human papilloma virus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology. 181:1991;62-69.
22. Alexander M, Salgaller M L, Celis E, Sette A, Barnes W A, Rosenberg S A, Steller M A. Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope. Am J Obstet Gynecol. 175:1996;1586-1593.
23. McFadden G, Kane K. How DNA viruses perturb functional MHC expression to alter immune recognition. Adv Cancer Res. 63:1994;117-209.
24. Connor M E, Stern P L. Loss of MHC Class-I expression in cervical carcinomas. Int J Cancer. 46:1990;1029-1034.
25. Honma S, Tsukada S, Honda S, Nakamura M, Takakuwa K, Maruhashi T. Biological-clinical significance of selective loss of HLA-class I allelic product expression in squamous-cell carcinoma of the uterine cervix. Int J Cancer. 57:1994;650-655.
26. Glew S S, Duggan-Keen M, Cabrera T, Stern P L. HLA Class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res. 52:1992;4009-4016.
27. Coleman N, Stanley M A. Analysis of HLA-DR expression on keratinocytes in cervical neoplesia. Int J Cancer. 56:1994;314-319.
28. Melief C JM, Kast W M. Lessons from T cell responses to virus induced tumors for cancer eradication in general. Cancer Surv. 13:1992;81-99.
29. Vanky F, Wang P, Patattoyo M, Klein E. Expression of the adhesion molecule ICAM-1 and the major histocompatibility complex antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol Immunother. 31:1990;19-27.
30. Anichini A, Mortarini R, Alberti S, Mantovani A, Parmiani G. T-cell-receptor engagment and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis. Int J Cancer. 53:1993;994-1001.
31. Taylor J L, Grossberg S E. Recent progress in interferon research: molecular mechanisms of regulation, action and virus circumvention. Virus Res. 15:1990;1-26.
32. Zamai L, Rana R, Mazzotti G, Centurione L, Di Pietro R, Vitale M. Lymphocyte binding to K562 cells: effects of target cell irradiation and correlation with ICAM-1 and LFA-3 expression. Eur J Histochem. 38:1994;53-60.
33. Dozmorov I M, Lee S Y, Park K-C. Effects of retinoids on regulatory cellular interactions in primary mixed limphocyte reaction (MLC). Immunopharmacol Immunotoxicol. 17:1995;665-685.
34. Jang X L, Dillehay D L, Eeverson M P, Tilden A B, Lamon E W. Potentiation of IL-2 induced T cell proliferation by retinoids. Int J Immunopharmacol. 14:1992;195-204.
35. Meunier L, Bohjanen K, Voorhees J J, Cooper K D. Retinoic acid upregulates human langerahans cell antigen presentation and surface expression of HLA-DR and CD11c, a β2 integrin critically involved in T cell activation. J Invest Dermatol. 103:1994;775-779.
36. Bouillon M, Tessier P, Boulianne R, Destrempe R, Audette M. Regulation by retinoic acid of ICAM-1 expression on human tumor cell lines. Biochem Biophys Acta. 1097:1993;95-102.
37. Gardner F JE, Walker R A. Modulation of cell surface components of human breast cancer cells by retinoic acid: enhanced HLA-DR expression. J Pathol. 170:1993;23-29.
38. Wang Z, Cao Y, D'urso C M, Ferrone S. Differential suseptibility of human melanoma cell lines to enhancement by retinoic acid of intracellular adhesion molecule I expression. Cancer Res. 52:1992;4766-4772.
39. Gross N, Beck D, Favre S, Carrel S. In vitro antigenic modulation of human neuroblastoma cells induced by IFN-γ, retinoic acid and dibutyryl cyclic AMP. Int J Cancer. 39:1987;521-529.
40. De Vries J E, Keizer G D, Te Velde A AT, Voordouw A, Ruiter D, Rumke P, Spits H, Figdor C G. Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells. Int J Cancer. 38:1986;465-473.